Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111592531A details a streamlined amidation-reduction process for Afuresertib, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel Silodosin preparation method reduces impurities significantly. High yield industrial process for reliable pharmaceutical intermediate supply chain.
Novel route for Midazolam via M2 intermediate avoids genotoxic impurities. High purity, scalable process for pharmaceutical manufacturing.
Advanced synthesis of nebivolol intermediates via diastereomeric cyanohydrins. Cost-effective route avoiding chromatography for reliable API manufacturing supply.
Patent CN106916857B reveals a three-enzyme system for high-purity L-glufosinate-ammonium. This breakthrough enables significant cost reduction and supply chain reliability.
Patent CN104447543B reveals a high-yield synthesis route for 3-amino-7,8-difluoroquinoline intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN114507650A details a high-efficiency biocatalytic route for Clopidogrel intermediates, offering superior stereoselectivity and substrate tolerance for scalable API manufacturing.
Novel enzymatic route for tofacitinib intermediate offers high purity and yield. Reduces cost and waste for pharmaceutical manufacturing supply chains.
Patent CN114958934A reveals a novel glutamate dehydrogenase method for L-glufosinate. Achieve high purity and cost reduction in agrochemical intermediate manufacturing.
Novel deamination route eliminates by-products for high-purity triazole bactericidal agent manufacturing ensuring cost reduction and supply reliability.
Patent CN103014081A details a green enzymatic route for 3-amino-4-(2,4,5-trifluorophenyl)methyl butyrate, offering superior chirality and cost reduction in pharmaceutical intermediate manufacturing.
Novel synthesis route for 3-methylamine tetrahydrofuran ensures high purity and cost efficiency for agrochemical intermediate supply chains globally.
Patent CN110885290A discloses a novel route for 3-fluoro-2-methyl-4-trifluoromethylaniline hydrochloride via Buchwald-Hartwig amination, ensuring high purity and scalable production for pharmaceutical intermediates.
Novel Mitsunobu-type condensation and reductive amination route for Cariprazine offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel enzymatic route for (S,S)-2,8-diazabicyclo[4,3,0]nonane. Reduces steps, avoids high-pressure hydrogenation. Reliable pharma intermediate supplier.
Novel borohydride reduction method ensures high purity and safety. Reliable pharmaceutical intermediates supplier offering cost-effective scale-up solutions.
Patent CN118324765A reveals a novel Ir-catalyzed route for Duvelisib, offering cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN111393333B details a green aqueous silver-catalyzed dearomatization method. This breakthrough offers high regioselectivity and scalable production for pharmaceutical intermediates.
Patent CN107540616B details a novel 4-step route to chiral pyrazolamines with 94% ee, offering significant cost reduction and supply chain reliability for agrochemical and pharmaceutical manufacturing.
Patent CN116924916B details a novel catalyst-free reductive amination method offering high selectivity and supply chain stability for pharmaceutical intermediates manufacturing.